The primary purpose of the Core B facility is to provide researchers of the NCDDG with rapid and cost effective high throughput screening, molecular modeling, and as a future direction, X-ray crystallography of their targets with the ultimate goal of identifying """"""""hits'for further chemical lead optimization and biological characterization. The Core B facility comprises two functional units: Experimental HTS and Virtual HTS &Molecular Modeling. The two units work closely together to provide complementary approaches toward screening molecular targets. The specific functions of Core B include: (1) Experimental HTS: To design, develop and employ biochemical assays formatted for HTS. To screen the combinatorial chemical libraries prepared by program 1 as well as publicly available chemical libraries, such as NCI Diversity and Natural Product Sets, in order to identify compounds capable of inhibiting the catalytic activities of geranylgeranyltransferase I (GGTase I), Rho guanine nucleotide exchange factors (RhoGEFs) and Rho kinase (ROCK). (2) Virtual HTS: To computationally dock libraries of small molecules from compound databases (>700,000 3D structures) onto defined surfaces of existing crystal structures in order to identify compounds that modulate the catalytic activities of GGTase I and RhoGEFs. (3) Molecular Modeling: The best scoring compounds from virtual screening and, in particular the experimentally confirmed """"""""hits"""""""" from virtual screening, as well as those from experimental HTS will be subjected to additional molecular modeling studies. (4) In Silica Prediction of ADME Properties: The QikProp program (Schrodinger, L.L.C.) will be employed to predict ADME properties of """"""""hits"""""""" and to optimize ADME properties of potential drug candidates. Data analysis and management: To facilitate communication among programs 1, 2 and 3 and Core A and B, we have set up a centralized database for all related scientific data. The maintenance of the infra-structure of the database is supported by the Moffitt Bioinformatics Services and Research IT (BRIT). Core B will be responsible for the management of the content. The database will allow users a) to register and track all compounds from synthesis/acquiring, shipment to testing;b) to search and review chemical and biological data from Programs 1,2, 3 and Core B.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program--Cooperative Agreements (U19)
Project #
5U19CA067771-15
Application #
7882872
Study Section
Special Emphasis Panel (ZCA1-SRRB-K (J1))
Project Start
2009-05-01
Project End
2010-04-30
Budget Start
2009-05-01
Budget End
2010-04-30
Support Year
15
Fiscal Year
2009
Total Cost
$246,512
Indirect Cost
Name
H. Lee Moffitt Cancer Center & Research Institute
Department
Type
DUNS #
139301956
City
Tampa
State
FL
Country
United States
Zip Code
33612
Patel, R A; Liu, Y; Wang, B et al. (2014) Identification of novel ROCK inhibitors with anti-migratory and anti-invasive activities. Oncogene 33:550-5
Vigil, Dominico; Kim, Tai Young; Plachco, Ana et al. (2012) ROCK1 and ROCK2 are required for non-small cell lung cancer anchorage-independent growth and invasion. Cancer Res 72:5338-47
Li, Rongshi; Martin, Mathew P; Liu, Yan et al. (2012) Fragment-based and structure-guided discovery and optimization of Rho kinase inhibitors. J Med Chem 55:2474-8
Pireddu, Roberta; Forinash, Kara D; Sun, Nan N et al. (2012) Pyridylthiazole-based ureas as inhibitors of Rho associated protein kinases (ROCK1 and 2). Medchemcomm 3:699-709
Mitin, Natalia; Roberts, Patrick J; Chenette, Emily J et al. (2012) Posttranslational lipid modification of Rho family small GTPases. Methods Mol Biol 827:87-95
Patel, Ronil A; Forinash, Kara D; Pireddu, Roberta et al. (2012) RKI-1447 is a potent inhibitor of the Rho-associated ROCK kinases with anti-invasive and antitumor activities in breast cancer. Cancer Res 72:5025-34
Neel, Nicole F; Martin, Timothy D; Stratford, Jeran K et al. (2011) The RalGEF-Ral Effector Signaling Network: The Road Less Traveled for Anti-Ras Drug Discovery. Genes Cancer 2:275-87
Berndt, Norbert; Sebti, Saïd M (2011) Measurement of protein farnesylation and geranylgeranylation in vitro, in cultured cells and in biopsies, and the effects of prenyl transferase inhibitors. Nat Protoc 6:1775-91
Cook, Danielle R; Solski, Patricia A; Bultman, Scott J et al. (2011) The ect2 rho Guanine nucleotide exchange factor is essential for early mouse development and normal cell cytokinesis and migration. Genes Cancer 2:932-42
Berndt, Norbert; Hamilton, Andrew D; Sebti, Saïd M (2011) Targeting protein prenylation for cancer therapy. Nat Rev Cancer 11:775-91

Showing the most recent 10 out of 117 publications